Bethge, Wolfgang A. http://orcid.org/0000-0001-6052-2618
Eyrich, Matthias http://orcid.org/0000-0002-8099-5903
Mielke, Stephan http://orcid.org/0000-0002-8325-9215
Meisel, Roland http://orcid.org/0000-0001-5230-0628
Niederwieser, Dietger http://orcid.org/0000-0002-4737-1103
Schlegel, Paul G.
Schulz, Ansgar http://orcid.org/0000-0002-7798-7996
Greil, Johann
Bunjes, Donald
Brecht, Arne
Kuball, Jurgen http://orcid.org/0000-0002-3914-7806
Schumm, Michael
Vucinic, Vladan
Wiesneth, Markus
Bonig, Halvard
Westinga, Kasper
Biedermann, Stefanie
Holtkamp, Silke
Karitzky, Sandra
Malchow, Michaela
Siewert, Christiane
Handgretinger, Rupert
Lang, Peter http://orcid.org/0000-0001-7737-2142
Article History
Received: 20 August 2021
Revised: 17 November 2021
Accepted: 6 December 2021
First Online: 24 December 2021
Competing interests
: WB: Consultancy and Research Funding—Miltenyi Biotec; Advisory Boards—Celgene, Novartis, Janssen, Gilead. ME: Clinical trial support and advisory boards—Bristol-Myers-Squibb. SM: Data safety monitoring board—Miltenyi, Immunicum; expert panel—Gilead/Kite, Bellicum; speaker’s fee—Novartis, DNA Prime SA, Cellex, Celgene, Kiadis Pharma, Jazz, Miltenyi; travel support—Cellex, Gilead/Kite, MSD, Celgene, Kiadis Pharma, Miltenyi. RM: Consulting or Advisory Role—Bluebird Bio, Bellicum Pharmaceuticals, Novartis; Travel, Accommodations, Expenses—Jazz Pharmaceuticals. DN: Advisory board—Cellectis; speakers bureau—Novartis, Daiichi; manuscript preparation support—Novartis. PGS: Advisory board—Bluebird Bio, not related to the topic of this publication. JK: Shareholder Gadeta and inventor on multiple patents dealing with gdT cell-related topics as well as CAR T isolation strategies; Research Support—Miltenyi Biotec, Novartis. HB: Research support: Bayer, Chugai, Erydel, Miltenyi, Polyphor, Sandoz-Hexal (a Novartis Company), Stage (a Celgene Company), Terumo BCT, Uniqure; honoraria/speakers‘ fees—Chugai, Fresenius, Genzyme, Kiadis, medac, Miltenyi, Novartis, Sandoz-Hexal, Terumo BCT; consultancy and advisory boards—Boehringer-Ingelheim, Celgene, Genzyme, medac, Novartis, Sandoz-Hexal, Stage, Terumo BCT; royalties—medac; stocks—Healthineers. KW: Advisory board—Novartis AG, not related to the topics of this publication. SB and CS are employees of Miltenyi Biotec. SH, SK, and MM are employees of Miltenyi Biomedicine. RH: Speakers’ honoraria—Miltenyi Biotec; co-patent holder of the TcR alpha-beta depletion. AB, DB, JG, PL, AS, MS, VV, MW: no conflict of interest.